These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8616046)

  • 1. Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis.
    Roelse JC; Koopman MM; Büller HR; ten Cate JW; Montaruli B; van Mourik JA; Voorbert J
    Br J Haematol; 1996 Mar; 92(3):740-3. PubMed ID: 8616046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations at the activated protein C cleavage sites Arg336 and Arg562 of factor VIII in Thai patients with venous thrombosis.
    Prayoonwiwat W; Arnutti P; Nathalang O; Suwanasophon C; Viputtigul K
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):880-3. PubMed ID: 12041568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for mutations in the genes for coagulation factors V and VIII with a possible predisposition to activated protein C resistance.
    Bokarewa MI; Falk G; Bremme K; Blombäck M; Wiman B
    Eur J Clin Invest; 1997 Apr; 27(4):340-5. PubMed ID: 9134384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis.
    Zöller B; Dahlbäck B
    Lancet; 1994 Jun; 343(8912):1536-8. PubMed ID: 7911873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation at either Arg336 or Arg562 in factor VIII is insufficient for complete resistance to activated protein C (APC)-mediated inactivation: implications for the APC resistance test.
    Amano K; Michnick DA; Moussalli M; Kaufman RJ
    Thromb Haemost; 1998 Mar; 79(3):557-63. PubMed ID: 9531040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.
    Voorberg J; Roelse J; Koopman R; Büller H; Berends F; ten Cate JW; Mertens K; van Mourik JA
    Lancet; 1994 Jun; 343(8912):1535-6. PubMed ID: 7911872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
    De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
    Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetics of venous thromboembolism.
    Dahlbäck B
    Ann Med; 1995 Apr; 27(2):187-92. PubMed ID: 7632412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene.
    Dahlbäck B
    Haemostasis; 1994; 24(2):139-51. PubMed ID: 7959362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
    Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
    N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C: role in venous and arterial thrombosis.
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Biomed Pharmacother; 1996; 50(6-7):254-60. PubMed ID: 8952864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of thrombin formation by activated protein C: effect of the factor V Leiden mutation.
    Tans G; Nicolaes GA; Rosing J
    Semin Hematol; 1997 Jul; 34(3):244-55. PubMed ID: 9241709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Point mutation G-->A nucleotide 1691 factor V gene as a cause of developing thrombotic complications in a family with plasma resistance to activated protein C].
    Lew Andowski KL; Rozek M; Turowiecka Z; Markiewicz WT; Zawilska K
    Pol Arch Med Wewn; 1996 May; 95(5):464-70. PubMed ID: 8848415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.